EUS in combination with fine-needle injection celiac plexus neurolysis from within a Wallstent stent

Abstract

Increasingly, EUS has become integrated into the management of GI tumors over the past decade.1,2 The development of EUS-guided fine-needle aspiration3-5 and, more recently, EUS-guided fine-needle injection (EUS-FNI) has expanded the clinical utility of interventional EUS.6 EUS is traditionally not used to stage cancers in patients with esophageal or enteral self-expandable metallic stent (SEMS) because such patients have unresectable malignant disease. There is also a commonly held belief that EUS cannot be performed through an SEMS (Fig.